7-Chloro-2-methyl-2H-pyrazolo[3,4-c]pyridine, 95.0%, 250mg

LIXIVAPTAN, 95%, 2mg

Screw vials free-standing, 0.5 ml, 500 Piece(s)

(S)-2-Amino-4-(4-bromophenyl)butanoic acid, 95%, 500mg

2-hydrazinylidene-5-(trifluoromethyl)-2,3-dihydro-1,3-benzothiazole, 97%, 500mg

(S)-1-((S)-2-Aminopropanoyl)pyrrolidine-2-carboxylic acid, 95.0%, 10g

N-(4-Benzyloxytrityl)-N'-(2-nitrobenzenesulfonyl)-1,2-diaminoethane Resin cross-linked with 1% DVB (200-400mesh) (0.9-1.1mmol/g)1g

3,3-Difluoropropan-1-amine hydrochloride, 98%, 100mg

1-(3,5-Difluoro-2-methoxyphenyl)ethanone, 97.0%, 1g

4-Ethyl-2-nitrophenol, 95.0%, 5g

Calcium Dobesilate Hydrate>98.0%(HPLC)1g

1-(2-Naphthalenyl)-2,3-butadien-1-one, 1g

1,3-Bis(3-glycidoxypropyl)tetramethyldisiloxane, 95%, 25g